RareSearch

8.7

Excellent

376 reviews

Communication: 8.8

Timeliness: 8.9

Accuracy: 7.6

Staff: 8.8

Value: 8.9

Arlene Kunze

🇺🇸 United States

9.3

Reviewed: September 14, 2023

- Project Management
- 10 weeks July - September 2023
- Biotech Company

Seamless project management, results exceeded expectations.

Project management was seamless, and the team exceeded our expectations. They handled all aspects of the project with professionalism and efficiency, keeping us informed every step of the way.

Lena Fisher

🇺🇸 United States

6.3

Reviewed: November 7, 2024

- Stability Studies
- 16 months July 2023 - November 2024
- Pharmaceutical Company

Stability studies lacked detail, required additional validation.

The stability studies conducted were lacking in detail, and we had to perform additional validation to ensure the results were reliable. This added extra time and cost to the project. The team was responsive to feedback, but the initial work was subpar.

Randal Hilpert

🇧🇷 Brazil

8.7

Reviewed: May 22, 2023

- Patient Recruitment
- 8 weeks March - April 2023
- Clinical Research Organization

Highly effective patient recruitment strategies, project completed on time.

The patient recruitment strategies were highly effective, and the project was completed within the agreed timeframe. The team was very professional, and their expertise in patient engagement was evident throughout.

Samuel Lubowitz

🇫🇷 France

Reviewed: June 9, 2024

- Process Development
- 12 weeks March - May 2024
- Biotech Company

Expert process development, enhanced efficiency.

The process development services enhanced our manufacturing efficiency significantly. The team's expertise in process optimization was evident, and they provided valuable insights that improved our production workflow.

Shelley Bode

🇪🇸 Spain

8.9

Reviewed: July 3, 2024

- Stability Studies
- 18 months January 2023 - June 2024
- Pharmaceutical Company

Accurate and reliable stability studies, clear reporting.

The stability studies were conducted with precision, and the reporting was clear and thorough. The results provided us with the necessary data to proceed with our regulatory submissions confidently.

Tommy Mraz

🇹🇷 Turkey

6.2

Reviewed: March 15, 2024

- Clinical Protocol Design
- 10 weeks January - March 2024
- Pharmaceutical Company

Inconsistent quality of deliverables, frequent revisions needed.

The protocol design process required multiple revisions due to inconsistencies in the deliverables. Although the team was responsive to feedback, the back-and-forth extended the timeline beyond what was originally agreed upon.